Balyasny Asset Management
STAA icon

Balyasny Asset Management’s STAAR Surgical STAA Stock Holding History

Balyasny Asset Management’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,000
Closed -$924K – 3493
2025
Q4 		$924K Buy
+40,000
New +$1.03M ﹤0.01% 2234

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
Anatole Investment Management Central, Hong Kong $716M AUM 502.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Balyasny Asset Management's STAA Position: Q1 2026 in Review

Balyasny Asset Management sold out of STAAR Surgical (STAA) in Q1 2026, closing a stake of 1,541,160 shares — an estimated $35.6M sold.

Balyasny Asset Management first reported a position in STAA in Q1 2018 and held it in 8 quarters. The position peaked at $48.7M in Q3 2025. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • Balyasny Asset Management reported no remaining STAAR Surgical position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 1,541,160 STAAR Surgical shares in Q1 2026, an estimated $35.6M.
  • Balyasny Asset Management first reported a position in STAAR Surgical in Q1 2018 and held it in 8 quarters.
  • Balyasny Asset Management's STAAR Surgical position peaked at $48.7M in Q3 2025.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.